Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Pleural Disease
Questions discussed in this category
What duration of antibiotic therapy do you use for a loculated parapneumonic effusion that does not meet criteria for empyema?
3 Answers available
What is the current recommendation for air travel after a primary spontaneous pneumothorax?
2 Answers available
Can transudative pleural effusions lead to trapped lung?
In trapped lung, a fibrous peel over the visceral pleura restricts pleural expansion. Could transudative pleural effusions lead to this condition?
1 Answer available
Would you consider deferring chest tube placement in a clinically stable patient with a small empyema without signs of systemic infection?
2 Answers available
Is a larger bore percutaneous chest tube sufficient to adequately drain a hemothorax, or is a surgical chest tube required?
1 Answer available
What is your approach to the evaluation and management of a suspected intrapulmonary hematoma?
1 Answer available
Do you use intrapleural tPA/dornase in loculated effusions that are not due to infection?
1 Answer available
How do you assess the use of Heimlich valves for patients who present with persistent air leaks?
1 Answer available
What is your approach to the management of persistent hydropneumothorax due to a non expandable lung?
1 Answer available
Is there any utility in using lytics for loculated malignant pleural effusion?
1 Answer available
Is an early chest tube and tPA/Dornase therapy for a loculated and complex pleural effusion that is not an empyema or hemothorax helpful in reducing the rate of developing trapped lung?
1 Answer available
Do you routinely continue using TPA/Dornase for treatment of empyema, if there is accumulation of new sero-sanguinous output from the chest tube after the initial treatment?
Are there any quantitative indices (eg. volume, pleural fluid hematocrit) that would impact your decision to stop subsequent TPA/dornase treatments?
1 Answer available
How do you approach treatment of septated parapneumonic pleural effusions that do not satisfy traditional criteria for complicated effusion after diagnostic thoracentesis?
Is there any role of tube thoracostomy as opposed to only antibiotics?
1 Answer available
What is the optimal frequency and duration of post-operative radiological surveillance following resection of a solitary fibrous tumor?
1 Answer available
How do you manage recurrent inflammatory pleural effusions in lupus pleuritis?
1 Answer available
Do you perform a clamp trial before removing a chest tube for pneumothorax?
2 Answers available
Do you give intrapleural lytics for complicated effusion/empyema in patients on systemic anticoagulation?
1 Answer available
Do you recommend the use of endobronchial valves in the management of patients with spontaneous pneumothorax with persistent air leak?
1 Answer available
Do you recommend the use of indwelling pleural catheters in the management of patients with hepatic hydrothorax requiring frequent drainage?
1 Answer available
What criteria do you use to consider pleurodesis vs indwelling tunneled catheters in patients with malignant pleural effusion?
1 Answer available
22306
18601
20377
19378
15451
17483
12556
16419
17175
16770
16450
16056
15819
15654
12991
13738
13501
12507
12506
12771
Papers discussed in this category
J Bronchology Interv Pulmonol, 2021 Nov 10
Indwelling Pleural Catheter (IPC) for the Management of Hepatic Hydrothorax: The Known and the Unknown.
Chest, 2015-09
Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study.
J Thorac Dis,
The use of thrombolytics in the management of complex pleural fluid collections.
Chest, 2011-06
Rapid pleurodesis for malignant pleural effusions: a pilot study.
JAMA,
Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
JAMA,
Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.
N Engl J Med,
Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
BMC Res Notes, 2020 Aug 03
Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study.
Respirology, 2022 Apr 19
Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
The journal of trauma and acute care surgery, 2014-11
Cleared for takeoff: The effects of hypobaric conditions on traumatic pneumothoraces.
International journal of circumpolar health, 2014
Safety of early air travel after treatment of traumatic pneumothorax.
Related Topics
Pulmonology
Interventional Pulmonology
Internal Medicine
Pleural Effusion
Pneumothorax
Thoracic Malignancies
Endobronchial Valve
Rheumatology
Systemic lupus erythematosus
Hemothorax